Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter March 2, 2022

Trimester-specific reference values for the anticardiolipin antibody by chemiluminescence immunoassay in healthy pregnancy

  • Rui Gao ORCID logo , Xinai Yue , Wanrong Huang , Fan Yu EMAIL logo and Lang Qin EMAIL logo

Corresponding author: Fan Yu, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, 23 Renmin South Road, Wuhou district, 610041 Chengdu, P.R. China; and Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu, P.R. China, E-mail: ; and Lang Qin, The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, P.R. China; and Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second University Hospital, Sichuan University, 23 Renmin South Road, Wuhou district, 610041 Chengdu, P.R. China, E-mail:
Rui Gao and Xinai Yue contributed equally to this work.

Award Identifier / Grant number: 2020YFS0107

Award Identifier / Grant number: 20PJ072

Acknowledgments

Thanks Eliot Wycoff, head of the American-owned Star Bridge Translation Company (Chinese business ID: 91510106MA68J7HD24) for editing this manuscript for readability.

  1. Research funding: This study was supported by the Health Department of Sichuan Province [grant number 20PJ072] and the Department of Science and Technology of Sichuan Province [grant number 2020YFS0107].

  2. Author contribution: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the institutional review board of West China Second University Hospital in Chengdu, China.

References

1. Ruiz-Irastorza, G, Crowther, M, Branch, W, Khamashta, MA. Antiphospholipid syndrome. Lancet 2010;376:1498–509. https://doi.org/10.1016/s0140-6736(10)60709-x.Search in Google Scholar

2. Bender Atik, R, Christiansen, OB, Elson, J, Kolte, AM, Lewis, S, Middeldorp, S, et al.. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018;2018:hoy004. https://doi.org/10.1093/hropen/hoy004.Search in Google Scholar PubMed PubMed Central

3. Xu, J, Chen, D, Duan, X, Li, L, Tang, Y, Peng, B. The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2019;98:1523–33. https://doi.org/10.1111/aogs.13665.Search in Google Scholar PubMed

4. Gao, R, Zeng, R, Qing, P, Meng, C, Cheng, K, Zhang, S, et al.. Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: a systematic review and meta-analysis. Am J Reprod Immunol 2021;84:e13470. https://doi.org/10.1111/aji.13470.Search in Google Scholar PubMed

5. De Carolis, S, Tabacco, S, Rizzo, F, Giannini, A, Botta, A, Salvi, S, et al.. Antiphospholipid syndrome: an update on risk factors for pregnancy outcome. Autoimmun Rev 2018;17:956–66. https://doi.org/10.1016/j.autrev.2018.03.018.Search in Google Scholar PubMed

6. Tektonidou, MG, Andreoli, L, Limper, M, Amoura, Z, Cervera, R, Costedoat-Chalumeau, N, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 2019;78:1296–304. https://doi.org/10.1136/annrheumdis-2019-215213.Search in Google Scholar PubMed

7. Cinquanta, L, Fontana, DE, Bizzaro, N. Chemiluminescent immunoassay Technology: what does it change in autoantibody detection? Auto Immun Highlights 2017;8:9. https://doi.org/10.1007/s13317-017-0097-2.Search in Google Scholar PubMed PubMed Central

8. Mahler, M, Bentow, C, Serra, J, Fritzler, MJ. Detection of autoantibodies using chemiluminescence technologies. Immunopharmacol Immunotoxicol 2016;38:14–20. https://doi.org/10.3109/08923973.2015.1077461.Search in Google Scholar PubMed PubMed Central

9. Pengo, V, Tripodi, A, Reber, G, Rand, JH, Ortel, TL, Galli, M, et al.. Update of the guidelines for lupus anticoagulant detection, subcommittee on lupus anticoagulant/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J Thromb Haemostasis 2009;7:1737–40. https://doi.org/10.1111/j.1538-7836.2009.03555.x.Search in Google Scholar PubMed

10. Yelnik, CM, Porter, TF, Branch, DW, Laskin, CA, Merrill, JT, Guerra, MM, et al.. Brief report: changes in antiphospholipid antibody titers during pregnancy: effects on pregnancy outcomes. Arthritis Rheumatol 2016;68:1964–9. https://doi.org/10.1002/art.39668.Search in Google Scholar PubMed PubMed Central

Received: 2021-08-06
Revised: 2022-02-10
Accepted: 2022-02-18
Published Online: 2022-03-02
Published in Print: 2022-05-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 29.3.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-0044/pdf
Scroll to top button